COVID-19: imbalanced cell-mediated immune response drives to immunopathology
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an imminent threat to humanity. SARS-CoV-2 invades host cells, causing a failure of host immune recognition. Instead of an effective antiviral immunological response after...
Main Authors: | Jun Wang, Qian Li, YuanWang Qiu, Hongzhou Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2122579 |
Similar Items
-
The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury
by: Giovanni Zarrilli, et al.
Published: (2021-01-01) -
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
by: Alessandro Allegra, et al.
Published: (2020-07-01) -
MicroRNA Let-7 Plays an Important Role in the Immunopathology of COVID-19: A Systematic Review
by: Renato Luís Pessôa, et al.
Published: (2023-03-01) -
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
by: Abdullahi Rabiu Abubakar, et al.
Published: (2022-03-01) -
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
by: Sara Lega, et al.
Published: (2020-05-01)